About
Small Molecules for stress, mood, behavior
Areas of Focus
Categories
Small Molecule PharmaceuticalNJ, NY, PA
Clinical Trials (8)
View allTotal Trials
8
As Lead Sponsor
8
As Collaborator
0
Total Enrollment
472
By Phase
PHASE1: 5PHASE2: 2PHASE1/PHASE2: 1
By Status
COMPLETED: 6UNKNOWN: 1TERMINATED: 1
Clinical Trials Pipeline8 trials
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Phase 1/2
Phase 2/3
N/A
2006
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
Today
Hover over trial bars to see details
Recent Trials
NCT02922166Lead Sponsor
Effects of SRX246 on an Experimental Model of Fear and Anxiety in Humans
PHASE1Unknown
36 participants
Started: Feb 3, 2017 · Completed: Dec 31, 2019
NCT02733614Lead Sponsor
Proof-of-concept Study to Assess the Efficacy and Safety of SRX246 in Adults With PTSD
PHASE2Terminated
33 participants
Started: Dec 31, 2016 · Completed: Mar 31, 2021
NCT02507284Lead Sponsor
Tolerability, Safety, and Activity of SRX246 in Irritable Subjects With Huntington's Disease
PHASE2Completed
106 participants
Started: May 10, 2016 · Completed: Dec 21, 2018
NCT02055638Lead Sponsor
Safety, Tolerability and Activity of SRX246 in Adults With Intermittent Explosive Disorder
PHASE1/PHASE2Completed
97 participants
Started: May 31, 2014 · Completed: May 31, 2016
NCT01088932Lead Sponsor
Multiple Dose Safety Study of SRX246 Capsules in Healthy Volunteers
PHASE1Completed
24 participants
Started: Mar 31, 2010 · Completed: Jul 31, 2010
Funding History (1)
D
Oct 18, 2013
Locations (1)
Headquarters
Bethlehem, PA, United States
Map
Loading map...